[18F]AlF-RESCA-IL2

N/A

Report date: 2025/10/20 14:27:28

Base Information

Drug Name[18F]AlF-RESCA-IL2

Drug Alias Name18F-AlF-RESCA-IL2

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionInterleukin-2 receptor modulators

TargetsInterleukin-2 receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Medical Center Groningen

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center Groningen

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A